Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
80 studies found for:    NOT (aplastic OR fanconi OR blackfan OR sickle OR telangiectasia) | Open Studies | Interventional Studies | anemia | United States
Show Display Options
Rank Status Study
1 Not yet recruiting Use of Cast Iron Pots to Improve Maternal Anemia
Condition: Iron-deficiency Anemia
Intervention: Device: Cast Iron Pot
2 Recruiting A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)
Condition: Iron Deficiency Anemia
Interventions: Drug: Ferumoxytol;   Drug: Ferric carboxymaltose
3 Recruiting Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia (IDA)
Condition: Iron Deficiency Anemia
Interventions: Drug: Iron isomaltoside;   Drug: Iron sucrose
4 Recruiting Expanded Access Study of HBOC-201 (Hemopure) for the Treatment of Life-Threatening Anemia
Condition: Anemia
Intervention: Biological: HBOC-201
5 Recruiting Iron Isomaltoside and Iron Sucrose for the Treatment of Iron Deficiency Anemia in Non-Dialysis-Dependent Chronic Kidney Disease
Condition: Iron Deficiency Anaemia
Interventions: Drug: Iron isomaltoside;   Drug: Iron Sucrose
6 Recruiting Optimized Erythropoietin (EPO) Treatment
Condition: Neonatal Anemia
Interventions: Drug: Epoetin Alpha;   Drug: Biotinylated Red Blood Cells
7 Recruiting Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
Conditions: Anemia;   Cardiovascular Disease
Interventions: Drug: EPO;   Drug: Feraheme
8 Not yet recruiting Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia
Conditions: Leukemia;   Myelofibrosis;   Anemia;   Splenomegaly
Interventions: Drug: Rigosertib;   Behavioral: Questionnaire
9 Recruiting Iron Supplement to Improve Iron Status Following Bariatric Surgery
Condition: Anemia, Iron Deficiency
Intervention: Dietary Supplement: Oral iron supplementation
10 Not yet recruiting An Extension Trial to Assess the Safety of Re-dosing of Iron Isomaltoside (Monofer®)
Condition: Iron-Deficiency Anemia
Intervention: Drug: Iron Isomaltoside
11 Not yet recruiting Deferasirox in Treating Patients With Very Low, Low, or Intermediate-Risk Red Blood Cell Transfusion Dependent Anemia or Myelodysplastic Syndrome
Conditions: Anemia;   Myelodysplastic Syndrome
Interventions: Drug: Deferasirox;   Other: Laboratory Biomarker Analysis
12 Recruiting Lenalidomide and Eltrombopag Olamine in Treating Patients With Symptomatic Anemia in Low or Intermediate Myelodysplastic Syndrome
Conditions: Adult Myelodysplastic Syndrome;   Anemia;   Chronic Myelomonocytic Leukemia
Interventions: Drug: Eltrombopag Olamine;   Other: Laboratory Biomarker Analysis;   Drug: Lenalidomide
13 Recruiting Pilot Study: Randomized, Placebo-controlled Comparator Trial of IV vs Oral Iron Treatment of RLS With IDA. (IVOR-IDA)
Conditions: Restless Legs Syndrome;   Iron Deficiency Anemia
Interventions: Drug: Ferumoxytol intravenous;   Drug: Ferrous sulfate
14 Not yet recruiting Randomized, Placebo-controlled Trial of Ferric Carboxymaltose in RLS Patients With Iron-deficiency Anemia
Condition: Restless Legs Syndrome (RLS)
Interventions: Drug: Injectafer® (Ferric Carboxymaltose - FCM);   Drug: Placebo (Normal Saline)
15 Recruiting Study of Sotatercept (ACE-011) in Subjects With Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis (MF) and Anemia
Condition: Leukemia
Intervention: Drug: Sotatercept
16 Recruiting Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of Multiple Doses of COR-001
Condition: Anemia
Interventions: Drug: COR-001;   Other: Placebo
17 Not yet recruiting Prevention of Transfusion Related Acute Gut Injury (TRAGI) in Extremely Low Gestational Age Neonates (ELGANs) Using iNO
Condition: Anemia
Interventions: Drug: Inhaled Nitric Oxide;   Drug: Placebo
18 Recruiting Transfusion of Biotinylated Red Blood Cells
Condition: Anemia
Intervention: Drug: Biotin-Labeled Red Blood Cells (RBCs)
19 Recruiting BioRBC Survival in Adults With Prior Antibody Response to BioRBCs
Condition: Anemia
Intervention: Drug: biotin labelled RBCs
20 Recruiting A Randomized Controlled Pilot Study of Goal-directed Iron Supplementation of Anemic, Critically Ill Trauma Patients With Functional Iron Deficiency, With and Without Oxandrolone
Conditions: Functional Iron Deficiency;   Trauma;   Anemia
Interventions: Drug: Iron sucrose;   Drug: Oxandrolone;   Other: IV iron placebo;   Other: Oxandrolone placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.